MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2021

    Accuracy of Frontal Assessment Battery to detect Mild Cognitive Impairment in a Cuban sample of Parkinson’s disease patients

    Y. Broche-Pérez, E. Jiménez-Puig, Z. Fernández-Fleites, S. Morales-Ortiz, LR. Crespo-Rodríguez (Santa Clara, Cuba)

    Objective: The aim of this study is to evaluate the accuracy (sensitivity and specificity) of Frontal Assessment Battery (FAB) for detecting executive deficits in a…
  • MDS Virtual Congress 2021

    The Relationship Between Leptin Levels and Cognitive Status and Disease Stages in Patients with Alzheimer’s Disease

    İ. Tuncer, G. Yuksel, H. Ti̇reli̇ (Kars, Turkey)

    Objective: The aim of this study is to determine the effect of leptin on pathogenesis in patients with Alzheimer type Dementia and Mild Cognitive Impairment…
  • MDS Virtual Congress 2021

    Sex-Specific APOE ε4 Association with Cognition in Lewy Body Dementia

    E. Bayram, S. Scholz, I. Litvan (La Jolla, USA)

    Objective: To evaluate whether association between apolipoprotein E ε4 (APOE ε4) and cognition differ for men and women with pathologically-confirmed Lewy body dementia (LBD). Background:…
  • MDS Virtual Congress 2021

    NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson’s Disease

    L. Gibson, T. Pollak, M. Hart, D. Trivedi, T. Nicholson, M. Zandi, K R. Chaudhuri, D. Aarsland (London, United Kingdom)

    Objective: To quantify the frequency of NMDA receptor (NMDAR) antibodies (Abs) in Parkinson’s disease (PD) and characterise their relationship with the cognitive and neuropsychiatric symptoms.…
  • MDS Virtual Congress 2021

    Falls in Parkinson’s Disease: The Impact of Cognitive Performance

    F. Rolim, A. Gomes, V. Santos, D. Torres, F. Carvalho (Fortaleza, Brazil)

    Objective: This study aimed to assess the incidence of falls in a population of PD patients and their clinical performance on cognitive assessment scales. Background:…
  • MDS Virtual Congress 2021

    Sex differences in brain and cognition in de novo PD patients

    J. Oltra, C. Uribe, A. Campabadal, A. Inguanzo, G. Monté-Rubio, M. Marti, Y. Compta, F. Valldeoriola, C. Junque, B. Segura (Barcelona, Spain)

    Objective: We aimed to investigate sex differences in brain atrophy and cognition in PD de novo patients through MRI subcortical volumetry and cortical thickness (CTh).…
  • MDS Virtual Congress 2021

    Impact of Restless Leg Syndrome (RLS) Severity on Cognitive Function and Depression

    K. Mangipudi, C. Adler, N. Zhang, H. Shill, S. Mehta, C. Belden, A. Atri, E. Driver-Dunckley (Scottsdale, USA)

    Objective: To determine whether cognitive dysfunction and depression are more prevalent in RLS subjects compared to controls, and if RLS severity impacts these variables. Background:…
  • MDS Virtual Congress 2020

    TAU pathology contributes to specific patterns of structural brain damage and neuropsychological heterogeneity in Huntington’s disease

    S. Martinez-Horta, J. Perez-Perez, R. Perez-Gonzalez, A. Horta-Barba, F. Sampedro, E. Rivas-Asensio, T. Xucla, M. Guasch, A. Campolongo, C. Izquierdo-Barrionuevo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: Explore the associations between CSF levels of neurofilament light chain (Nfl), total TAU (tTAU) and phosphorylated TAU (pTAU), structural brain damage and cognitive performance…
  • MDS Virtual Congress 2020

    White Matter Changes and Early Cognitive Impairment in Parkinson’s Disease

    T. Belal, S. Elgamal (Mansoura, Egypt)

    Objective: Studying white matter changes in Parkinson's disease patients using diffusion tensor imaging; and its relation to cognition and motor symptoms impairment. Background: Cognitive dysfunction…
  • MDS Virtual Congress 2020

    The effect of Deep Brain Stimulation in patients with Parkinson’s Disease on the Brain Cognitive Functions

    A. Ivashynka, A. Cucovici (Novara, Italy)

    Objective: To evaluate the effect of Deep Brain Stimulation (DBS) on cognitive functions and affective symptoms in patients with Parkinson's Disease (PD). Background: DBS helps…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • VIT-D and Tics Movement Disorder
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley